Trial Information
Summary: HIV Patients Taking a HAART Regimen Including Atanazavir
People with HIV are asked to participate in a research study
being conducted at North Shore University Hospital.
You may be eligible to participate in this study if
you:
- Are male or female at least 18 years of age.
- Are experiencing virological failure on a HAART regimen
containing atanazavir (ATV).
You may not participate in this study if
you
- Are not taking atanazavir (ATV)
For more information,
|
Contact:
Vance Viverito, Study Coordinator
Biomedical Research Alliance of New York
North Shore University Hospital
300 Community Drive
4th Floor Lippert
Manhasset, NY 11030
Telephone: 516-562-4610
Fax: 516-562-4028
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:44:22 AM